Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Complement C5 inhibition in patients with COVID-19 - a promising target?

23 Jul 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Complement system in diseases
Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33256385
DOI: 10.3324/haematol.2020.260117

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Complement C5 inhibition in patients with COVID-19 - a promising target?PMID 33256385Read ↗

Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19Semantic proximity Read ↗

The Complement C5a-C5aR1 GPCR Axis in COVID-19 TherapeuticsSemantic proximity Read ↗

Complement control for COVID-19Semantic proximity Read ↗

Complement cascade in severe forms of COVID‐19: Recent advances in therapySemantic proximity Read ↗

Complement Inhibition and COVID-19: The Story so FarSemantic proximity Read ↗

Severe COVID-19 is associated with hyperactivation of the alternative complement pathwaySemantic proximity Read ↗

Complement as a target in COVID-19?Semantic proximity Read ↗

Compstatins: the dawn of clinical C3-targeted complement inhibitionSemantic proximity Read ↗

Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacySemantic proximity Read ↗

Complement‐targeted therapeutics: Are we there yet, or just getting started?Semantic proximity Read ↗

Complement in human disease: approved and up-and-coming therapeuticsSemantic proximity Read ↗

The alternative pathway of complement in disease: opportunities for therapeutic targetingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.